

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of water loss via skin (GO:0033561) | 9.64791155 |
| 2 | keratinization (GO:0031424) | 9.21577405 |
| 3 | multicellular organismal water homeostasis (GO:0050891) | 6.56828298 |
| 4 | keratinocyte differentiation (GO:0030216) | 6.22386622 |
| 5 | sphingoid metabolic process (GO:0046519) | 5.84796353 |
| 6 | behavioral response to nicotine (GO:0035095) | 5.83460238 |
| 7 | hair cycle (GO:0042633) | 5.60170310 |
| 8 | molting cycle (GO:0042303) | 5.60170310 |
| 9 | keratinocyte proliferation (GO:0043616) | 5.49965731 |
| 10 | regulation of somitogenesis (GO:0014807) | 5.38503036 |
| 11 | sphingosine metabolic process (GO:0006670) | 5.35150899 |
| 12 | water homeostasis (GO:0030104) | 5.34456369 |
| 13 | glucosamine-containing compound catabolic process (GO:1901072) | 5.23126717 |
| 14 | epidermal cell differentiation (GO:0009913) | 4.97570908 |
| 15 | keratinocyte development (GO:0003334) | 4.89580516 |
| 16 | diol metabolic process (GO:0034311) | 4.81340490 |
| 17 | peptide cross-linking (GO:0018149) | 4.69384188 |
| 18 | hemidesmosome assembly (GO:0031581) | 4.66534050 |
| 19 | epidermis development (GO:0008544) | 4.56971861 |
| 20 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 4.46858272 |
| 21 | intermediate filament organization (GO:0045109) | 4.39657196 |
| 22 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.35422582 |
| 23 | long-chain fatty acid biosynthetic process (GO:0042759) | 4.35419568 |
| 24 | regulation of phospholipase A2 activity (GO:0032429) | 4.30975684 |
| 25 | detection of bacterium (GO:0016045) | 4.28651582 |
| 26 | ectoderm development (GO:0007398) | 4.16242770 |
| 27 | detection of other organism (GO:0098543) | 4.11670323 |
| 28 | L-fucose catabolic process (GO:0042355) | 4.10894827 |
| 29 | fucose catabolic process (GO:0019317) | 4.10894827 |
| 30 | L-fucose metabolic process (GO:0042354) | 4.10894827 |
| 31 | positive regulation of interleukin-8 secretion (GO:2000484) | 4.10883209 |
| 32 | negative regulation of keratinocyte proliferation (GO:0010839) | 4.08044826 |
| 33 | cellular ketone body metabolic process (GO:0046950) | 4.02770583 |
| 34 | regulation of chemokine secretion (GO:0090196) | 3.98258851 |
| 35 | indolalkylamine metabolic process (GO:0006586) | 3.88391827 |
| 36 | regulation of cell proliferation involved in kidney development (GO:1901722) | 3.81130693 |
| 37 | indole-containing compound catabolic process (GO:0042436) | 3.71109231 |
| 38 | indolalkylamine catabolic process (GO:0046218) | 3.71109231 |
| 39 | tryptophan catabolic process (GO:0006569) | 3.71109231 |
| 40 | regulation of interleukin-8 secretion (GO:2000482) | 3.68478474 |
| 41 | lipoxygenase pathway (GO:0019372) | 3.61505849 |
| 42 | ketone body metabolic process (GO:1902224) | 3.61486767 |
| 43 | protein polyglutamylation (GO:0018095) | 3.47423038 |
| 44 | monocyte chemotaxis (GO:0002548) | 3.37338897 |
| 45 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.36824573 |
| 46 | drug catabolic process (GO:0042737) | 3.36244024 |
| 47 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.34940256 |
| 48 | nephron tubule morphogenesis (GO:0072078) | 3.34704830 |
| 49 | nephron epithelium morphogenesis (GO:0072088) | 3.34704830 |
| 50 | superoxide anion generation (GO:0042554) | 3.32991860 |
| 51 | gland morphogenesis (GO:0022612) | 3.32392266 |
| 52 | regulation of male gonad development (GO:2000018) | 3.32043000 |
| 53 | positive regulation of hair follicle development (GO:0051798) | 3.28376905 |
| 54 | positive regulation of hair cycle (GO:0042635) | 3.28376905 |
| 55 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.27614399 |
| 56 | kynurenine metabolic process (GO:0070189) | 3.26814810 |
| 57 | detection of light stimulus involved in visual perception (GO:0050908) | 3.26569505 |
| 58 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.26569505 |
| 59 | regulation of ruffle assembly (GO:1900027) | 3.23403470 |
| 60 | exogenous drug catabolic process (GO:0042738) | 3.22519031 |
| 61 | positive regulation of odontogenesis (GO:0042482) | 3.20295857 |
| 62 | cornea development in camera-type eye (GO:0061303) | 3.19800600 |
| 63 | axoneme assembly (GO:0035082) | 3.16350522 |
| 64 | G-protein coupled receptor internalization (GO:0002031) | 3.15072745 |
| 65 | regulation of Wnt signaling pathway involved in heart development (GO:0003307) | 3.14867047 |
| 66 | positive regulation of chemokine secretion (GO:0090197) | 3.14118070 |
| 67 | tryptophan metabolic process (GO:0006568) | 3.13875761 |
| 68 | positive regulation of mitochondrial membrane permeability (GO:0035794) | 3.12514796 |
| 69 | protein localization to cilium (GO:0061512) | 3.11640817 |
| 70 | chemical homeostasis within a tissue (GO:0048875) | 3.10504056 |
| 71 | cyclooxygenase pathway (GO:0019371) | 3.07372684 |
| 72 | glycerophospholipid catabolic process (GO:0046475) | 3.06272650 |
| 73 | S-adenosylmethionine metabolic process (GO:0046500) | 3.02980014 |
| 74 | regulation of keratinocyte proliferation (GO:0010837) | 3.02929622 |
| 75 | interferon-gamma secretion (GO:0072643) | 3.01784486 |
| 76 | piRNA metabolic process (GO:0034587) | 2.94270119 |
| 77 | atrioventricular valve morphogenesis (GO:0003181) | 2.92656139 |
| 78 | cellular biogenic amine catabolic process (GO:0042402) | 2.91706396 |
| 79 | amine catabolic process (GO:0009310) | 2.91706396 |
| 80 | neural crest cell development (GO:0014032) | 2.91070239 |
| 81 | synaptic transmission, cholinergic (GO:0007271) | 2.90945440 |
| 82 | DNA deamination (GO:0045006) | 2.89522911 |
| 83 | regulation of action potential (GO:0098900) | 2.88717785 |
| 84 | indole-containing compound metabolic process (GO:0042430) | 2.86609132 |
| 85 | limb bud formation (GO:0060174) | 2.84382886 |
| 86 | negative regulation of stress fiber assembly (GO:0051497) | 2.83982179 |
| 87 | primary amino compound metabolic process (GO:1901160) | 2.82978410 |
| 88 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.82963437 |
| 89 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.82963437 |
| 90 | NADH dehydrogenase complex assembly (GO:0010257) | 2.82963437 |
| 91 | respiratory chain complex IV assembly (GO:0008535) | 2.82584014 |
| 92 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.82045666 |
| 93 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.81930108 |
| 94 | protein complex biogenesis (GO:0070271) | 2.81765713 |
| 95 | startle response (GO:0001964) | 2.81740894 |
| 96 | retinal cone cell development (GO:0046549) | 2.81731173 |
| 97 | positive regulation of fatty acid transport (GO:2000193) | 2.81510027 |
| 98 | epithelial cilium movement (GO:0003351) | 2.80923892 |
| 99 | detection of external biotic stimulus (GO:0098581) | 2.80783223 |
| 100 | dendritic spine morphogenesis (GO:0060997) | 2.80574662 |
| 101 | regulation of hypersensitivity (GO:0002883) | 2.80351109 |
| 102 | establishment of tissue polarity (GO:0007164) | 2.78903510 |
| 103 | establishment of planar polarity (GO:0001736) | 2.78903510 |
| 104 | aromatic amino acid family catabolic process (GO:0009074) | 2.77182280 |
| 105 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.74877773 |
| 106 | kidney morphogenesis (GO:0060993) | 2.74616892 |
| 107 | DNA methylation involved in gamete generation (GO:0043046) | 2.74205088 |
| 108 | peristalsis (GO:0030432) | 2.73346769 |
| 109 | T-helper cell differentiation (GO:0042093) | 2.71807553 |
| 110 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.71807553 |
| 111 | histone H3-K36 demethylation (GO:0070544) | 2.71350482 |
| 112 | sympathetic nervous system development (GO:0048485) | 2.70977161 |
| 113 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.70598138 |
| 114 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.70382603 |
| 115 | positive regulation of male gonad development (GO:2000020) | 2.70142282 |
| 116 | nucleobase catabolic process (GO:0046113) | 2.70133697 |
| 117 | positive regulation of heat generation (GO:0031652) | 2.69697795 |
| 118 | regulation of glomerular filtration (GO:0003093) | 2.69397387 |
| 119 | ubiquinone biosynthetic process (GO:0006744) | 2.69320120 |
| 120 | renal tubule morphogenesis (GO:0061333) | 2.68423707 |
| 121 | negative regulation of mast cell activation (GO:0033004) | 2.68213436 |
| 122 | adaptation of signaling pathway (GO:0023058) | 2.67235909 |
| 123 | GPI anchor metabolic process (GO:0006505) | 2.67028480 |
| 124 | reflex (GO:0060004) | 2.66422535 |
| 125 | platelet dense granule organization (GO:0060155) | 2.66419096 |
| 126 | skin morphogenesis (GO:0043589) | 2.65856515 |
| 127 | oxidative demethylation (GO:0070989) | 2.65252659 |
| 128 | neuronal action potential (GO:0019228) | 2.65232657 |
| 129 | regulation of hair follicle development (GO:0051797) | 2.65116324 |
| 130 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.64772201 |
| 131 | positive regulation of glomerulus development (GO:0090193) | 2.64619648 |
| 132 | amino sugar catabolic process (GO:0046348) | 2.64127611 |
| 133 | intermediate filament cytoskeleton organization (GO:0045104) | 2.63775465 |
| 134 | nonmotile primary cilium assembly (GO:0035058) | 2.62607595 |
| 135 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 2.62411657 |
| 136 | regulation of hippo signaling (GO:0035330) | 2.61789983 |
| 137 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.61504356 |
| 138 | intermediate filament-based process (GO:0045103) | 2.60981842 |
| 139 | phasic smooth muscle contraction (GO:0014821) | 2.60604404 |
| 140 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 2.60373643 |
| 141 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.59030391 |
| 142 | alanine transport (GO:0032328) | 2.58817695 |
| 143 | negative regulation of telomere maintenance (GO:0032205) | 2.57659802 |
| 144 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 2.57634245 |
| 145 | phospholipid scrambling (GO:0017121) | 2.57260710 |
| 146 | positive regulation of interleukin-1 secretion (GO:0050716) | 2.56648525 |
| 147 | regulation of hair cycle (GO:0042634) | 2.55161649 |
| 148 | eyelid development in camera-type eye (GO:0061029) | 2.54950800 |
| 149 | ubiquinone metabolic process (GO:0006743) | 2.53704454 |
| 150 | serotonin metabolic process (GO:0042428) | 2.53248201 |
| 151 | positive regulation of icosanoid secretion (GO:0032305) | 2.53123868 |
| 152 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.52721272 |
| 153 | arginine metabolic process (GO:0006525) | 2.52667197 |
| 154 | negative regulation of stem cell proliferation (GO:2000647) | 2.51983162 |
| 155 | positive regulation of interleukin-1 beta production (GO:0032731) | 2.50328821 |
| 156 | surfactant homeostasis (GO:0043129) | 2.49249452 |
| 157 | positive regulation of sodium ion transmembrane transport (GO:1902307) | 2.49183992 |
| 158 | positive regulation of epidermis development (GO:0045684) | 2.47832738 |
| 159 | photoreceptor cell maintenance (GO:0045494) | 2.47690048 |
| 160 | sulfation (GO:0051923) | 2.47564878 |
| 161 | alkaloid metabolic process (GO:0009820) | 2.47521944 |
| 162 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.47320196 |
| 163 | positive regulation of prostaglandin secretion (GO:0032308) | 2.47196399 |
| 164 | negative regulation of cell fate specification (GO:0009996) | 2.47100060 |
| 165 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.46382175 |
| 166 | inositol phosphate catabolic process (GO:0071545) | 2.45949055 |
| 167 | mannosylation (GO:0097502) | 2.45444303 |
| 168 | epithelium development (GO:0060429) | 2.44627746 |
| 169 | gamma-aminobutyric acid transport (GO:0015812) | 2.44285988 |
| 170 | cilium morphogenesis (GO:0060271) | 2.44236742 |
| 171 | C4-dicarboxylate transport (GO:0015740) | 2.44033590 |
| 172 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.43929724 |
| 173 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.43584107 |
| 174 | eosinophil chemotaxis (GO:0048245) | 2.43071576 |
| 175 | regulation of fever generation (GO:0031620) | 2.42722659 |
| 176 | positive regulation of cholesterol efflux (GO:0010875) | 2.41243796 |
| 177 | regulation of hexokinase activity (GO:1903299) | 2.40286495 |
| 178 | regulation of glucokinase activity (GO:0033131) | 2.40286495 |
| 179 | auditory receptor cell stereocilium organization (GO:0060088) | 2.40171710 |
| 180 | negative regulation of axon guidance (GO:1902668) | 2.39385781 |
| 181 | detection of biotic stimulus (GO:0009595) | 2.38722350 |
| 182 | rhodopsin mediated signaling pathway (GO:0016056) | 2.38234623 |
| 183 | cytochrome complex assembly (GO:0017004) | 2.37735605 |
| 184 | lymph vessel development (GO:0001945) | 2.36712299 |
| 185 | action potential (GO:0001508) | 2.36658121 |
| 186 | sulfate transmembrane transport (GO:1902358) | 2.36273437 |
| 187 | inositol phosphate dephosphorylation (GO:0046855) | 2.36137910 |
| 188 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 2.36137910 |
| 189 | negative regulation of reactive oxygen species metabolic process (GO:2000378) | 2.36008496 |
| 190 | transepithelial transport (GO:0070633) | 2.35364723 |
| 191 | cell morphogenesis involved in neuron differentiation (GO:0048667) | 2.35092249 |
| 192 | organic cation transport (GO:0015695) | 2.34886252 |
| 193 | arginine catabolic process (GO:0006527) | 2.34306225 |
| 194 | transmission of nerve impulse (GO:0019226) | 2.34168430 |
| 195 | regulation of interleukin-1 beta secretion (GO:0050706) | 2.34101503 |
| 196 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.33494716 |
| 197 | cilium organization (GO:0044782) | 2.33350416 |
| 198 | desmosome organization (GO:0002934) | 11.9154660 |
| 199 | establishment of skin barrier (GO:0061436) | 11.1066623 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 4.58493467 |
| 2 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.54017013 |
| 3 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.00040476 |
| 4 | VDR_22108803_ChIP-Seq_LS180_Human | 2.98250628 |
| 5 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 2.65456452 |
| 6 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.64604220 |
| 7 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.57077752 |
| 8 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.53436538 |
| 9 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 2.20956180 |
| 10 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.07493407 |
| 11 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 11.7665852 |
| 12 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.99223913 |
| 13 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.96767684 |
| 14 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.96179749 |
| 15 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.95736064 |
| 16 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.88353563 |
| 17 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.83340508 |
| 18 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.76408780 |
| 19 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.76039989 |
| 20 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.72088188 |
| 21 | FUS_26573619_Chip-Seq_HEK293_Human | 1.71763803 |
| 22 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.70514804 |
| 23 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.69907929 |
| 24 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.69530737 |
| 25 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.62698956 |
| 26 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.58931114 |
| 27 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.58818847 |
| 28 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.58086368 |
| 29 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.54651051 |
| 30 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.54640642 |
| 31 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.54146289 |
| 32 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.54098275 |
| 33 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.53904208 |
| 34 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.53511104 |
| 35 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.53127809 |
| 36 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.51971027 |
| 37 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.50706447 |
| 38 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.49994845 |
| 39 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.49994845 |
| 40 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.49855095 |
| 41 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.49679449 |
| 42 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.48270258 |
| 43 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.48098984 |
| 44 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.48021397 |
| 45 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.44774081 |
| 46 | STAT3_23295773_ChIP-Seq_U87_Human | 1.42345181 |
| 47 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.42295266 |
| 48 | CJUN_26792858_Chip-Seq_BT549_Human | 1.42294711 |
| 49 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.41037311 |
| 50 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.41037311 |
| 51 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.39984453 |
| 52 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.39619409 |
| 53 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.39280503 |
| 54 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.39214262 |
| 55 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.37935771 |
| 56 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.37793020 |
| 57 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.37597967 |
| 58 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.36337593 |
| 59 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.34682498 |
| 60 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.33549653 |
| 61 | RXR_22108803_ChIP-Seq_LS180_Human | 1.33469355 |
| 62 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.33179790 |
| 63 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.32913349 |
| 64 | TCF4_23295773_ChIP-Seq_U87_Human | 1.30936807 |
| 65 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.30893143 |
| 66 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.30635209 |
| 67 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 1.30127313 |
| 68 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.28125953 |
| 69 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.26381747 |
| 70 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.26381747 |
| 71 | NCOR_22424771_ChIP-Seq_293T_Human | 1.25706672 |
| 72 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.24494922 |
| 73 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.22966781 |
| 74 | * GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.22752120 |
| 75 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.22527586 |
| 76 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.22344006 |
| 77 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.22344006 |
| 78 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.21901172 |
| 79 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.21420540 |
| 80 | TP53_16413492_ChIP-PET_HCT116_Human | 1.21274393 |
| 81 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.20794460 |
| 82 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.20776900 |
| 83 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.20454853 |
| 84 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.18592611 |
| 85 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.18592611 |
| 86 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.18350953 |
| 87 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.18186596 |
| 88 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.17604363 |
| 89 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.16767323 |
| 90 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.16025265 |
| 91 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.15886119 |
| 92 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.15655123 |
| 93 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.15385270 |
| 94 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.14581467 |
| 95 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.14521103 |
| 96 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.14305802 |
| 97 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.13789797 |
| 98 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 1.13763940 |
| 99 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.12997592 |
| 100 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.12353333 |
| 101 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.11945204 |
| 102 | AR_20517297_ChIP-Seq_VCAP_Human | 1.10920861 |
| 103 | ERA_21632823_ChIP-Seq_H3396_Human | 1.10736830 |
| 104 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.10381942 |
| 105 | P300_19829295_ChIP-Seq_ESCs_Human | 1.09451322 |
| 106 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.09316364 |
| 107 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.09027841 |
| 108 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.08907211 |
| 109 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.08735813 |
| 110 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.08067048 |
| 111 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.07990982 |
| 112 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.07801067 |
| 113 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.07665524 |
| 114 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.07094756 |
| 115 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.06881885 |
| 116 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.06003969 |
| 117 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.05943437 |
| 118 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.04470119 |
| 119 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.02792788 |
| 120 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.02666216 |
| 121 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.02152607 |
| 122 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.01541983 |
| 123 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.01518432 |
| 124 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.01509456 |
| 125 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.01388123 |
| 126 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.01078386 |
| 127 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.01007924 |
| 128 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.00146898 |
| 129 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.00139610 |
| 130 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.99938927 |
| 131 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.99746341 |
| 132 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.99338269 |
| 133 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.99238813 |
| 134 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.99097181 |
| 135 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.98352582 |
| 136 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.97554989 |
| 137 | EWS_26573619_Chip-Seq_HEK293_Human | 0.97213015 |
| 138 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.96811086 |
| 139 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.96749160 |
| 140 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.96659976 |
| 141 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.96563317 |
| 142 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.96396166 |
| 143 | * FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.96218279 |
| 144 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.95990768 |
| 145 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.95787533 |
| 146 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.94938028 |
| 147 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.94921322 |
| 148 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.94804326 |
| 149 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.93425505 |
| 150 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.93275651 |
| 151 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.92592326 |
| 152 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.92592326 |
| 153 | RBPJ_21746931_ChIP-Seq_IB4_Human | 0.92097717 |
| 154 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.92033664 |
| 155 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.91894272 |
| 156 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.91323292 |
| 157 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.90884850 |
| 158 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.90238700 |
| 159 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.89226254 |
| 160 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.88088354 |
| 161 | AR_25329375_ChIP-Seq_VCAP_Human | 0.88086414 |
| 162 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 0.86973173 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002796_impaired_skin_barrier | 6.58708205 |
| 2 | MP0003941_abnormal_skin_development | 5.49751867 |
| 3 | MP0010234_abnormal_vibrissa_follicle | 5.04496668 |
| 4 | MP0005275_abnormal_skin_tensile | 4.95869974 |
| 5 | MP0004381_abnormal_hair_follicle | 4.65283062 |
| 6 | MP0000579_abnormal_nail_morphology | 4.23371566 |
| 7 | MP0005501_abnormal_skin_physiology | 4.19749483 |
| 8 | MP0002098_abnormal_vibrissa_morphology | 3.40641044 |
| 9 | MP0003195_calcinosis | 3.29792865 |
| 10 | MP0003646_muscle_fatigue | 3.17492590 |
| 11 | MP0000566_synostosis | 3.12365697 |
| 12 | MP0005451_abnormal_body_composition | 3.07440935 |
| 13 | MP0001216_abnormal_epidermal_layer | 3.05049189 |
| 14 | MP0002060_abnormal_skin_morphology | 3.01268174 |
| 15 | MP0000383_abnormal_hair_follicle | 2.86643484 |
| 16 | MP0010678_abnormal_skin_adnexa | 2.84647601 |
| 17 | MP0002837_dystrophic_cardiac_calcinosis | 2.71006767 |
| 18 | MP0001346_abnormal_lacrimal_gland | 2.62682807 |
| 19 | MP0010771_integument_phenotype | 2.60154353 |
| 20 | MP0000647_abnormal_sebaceous_gland | 2.58272103 |
| 21 | MP0002876_abnormal_thyroid_physiology | 2.41948392 |
| 22 | MP0005551_abnormal_eye_electrophysiolog | 2.40110181 |
| 23 | MP0000377_abnormal_hair_follicle | 2.26567785 |
| 24 | MP0008875_abnormal_xenobiotic_pharmacok | 2.24148733 |
| 25 | MP0003453_abnormal_keratinocyte_physiol | 2.21286810 |
| 26 | MP0004043_abnormal_pH_regulation | 2.16442192 |
| 27 | MP0008877_abnormal_DNA_methylation | 2.14746522 |
| 28 | MP0000427_abnormal_hair_cycle | 2.13997726 |
| 29 | MP0001968_abnormal_touch/_nociception | 2.13893848 |
| 30 | MP0009046_muscle_twitch | 2.09783555 |
| 31 | MP0004145_abnormal_muscle_electrophysio | 2.09056993 |
| 32 | MP0004947_skin_inflammation | 2.07929202 |
| 33 | MP0003136_yellow_coat_color | 2.05385858 |
| 34 | MP0001501_abnormal_sleep_pattern | 1.99964273 |
| 35 | MP0001986_abnormal_taste_sensitivity | 1.97559515 |
| 36 | MP0006276_abnormal_autonomic_nervous | 1.94486984 |
| 37 | MP0004142_abnormal_muscle_tone | 1.93209748 |
| 38 | MP0005257_abnormal_intraocular_pressure | 1.86474894 |
| 39 | MP0004133_heterotaxia | 1.83601323 |
| 40 | MP0009745_abnormal_behavioral_response | 1.78637122 |
| 41 | MP0002638_abnormal_pupillary_reflex | 1.76645676 |
| 42 | MP0000569_abnormal_digit_pigmentation | 1.76536274 |
| 43 | MP0005646_abnormal_pituitary_gland | 1.72565837 |
| 44 | MP0000762_abnormal_tongue_morphology | 1.71123722 |
| 45 | MP0003878_abnormal_ear_physiology | 1.68238220 |
| 46 | MP0005377_hearing/vestibular/ear_phenot | 1.68238220 |
| 47 | MP0002009_preneoplasia | 1.67497722 |
| 48 | MP0002254_reproductive_system_inflammat | 1.66756358 |
| 49 | MP0004147_increased_porphyrin_level | 1.64056764 |
| 50 | MP0000467_abnormal_esophagus_morphology | 1.60175775 |
| 51 | MP0008872_abnormal_physiological_respon | 1.59233514 |
| 52 | MP0000013_abnormal_adipose_tissue | 1.55437687 |
| 53 | MP0004885_abnormal_endolymph | 1.55232849 |
| 54 | MP0002272_abnormal_nervous_system | 1.54936557 |
| 55 | MP0005253_abnormal_eye_physiology | 1.52910157 |
| 56 | MP0002277_abnormal_respiratory_mucosa | 1.52881714 |
| 57 | MP0001486_abnormal_startle_reflex | 1.49367072 |
| 58 | MP0001191_abnormal_skin_condition | 1.48660505 |
| 59 | MP0002736_abnormal_nociception_after | 1.43724908 |
| 60 | MP0006072_abnormal_retinal_apoptosis | 1.43414824 |
| 61 | MP0003122_maternal_imprinting | 1.43320778 |
| 62 | MP0000465_gastrointestinal_hemorrhage | 1.42628465 |
| 63 | MP0001502_abnormal_circadian_rhythm | 1.41850093 |
| 64 | MP0002909_abnormal_adrenal_gland | 1.41545849 |
| 65 | MP0005365_abnormal_bile_salt | 1.41080985 |
| 66 | MP0002733_abnormal_thermal_nociception | 1.38012325 |
| 67 | MP0009931_abnormal_skin_appearance | 1.36413874 |
| 68 | MP0005332_abnormal_amino_acid | 1.35298891 |
| 69 | MP0003137_abnormal_impulse_conducting | 1.32437656 |
| 70 | MP0005248_abnormal_Harderian_gland | 1.29395021 |
| 71 | MP0001851_eye_inflammation | 1.29311367 |
| 72 | MP0002234_abnormal_pharynx_morphology | 1.28877510 |
| 73 | MP0002163_abnormal_gland_morphology | 1.28635617 |
| 74 | MP0010329_abnormal_lipoprotein_level | 1.27650879 |
| 75 | MP0000367_abnormal_coat/_hair | 1.26369237 |
| 76 | MP0004215_abnormal_myocardial_fiber | 1.26238904 |
| 77 | MP0002572_abnormal_emotion/affect_behav | 1.25556972 |
| 78 | MP0005367_renal/urinary_system_phenotyp | 1.25379356 |
| 79 | MP0000516_abnormal_urinary_system | 1.25379356 |
| 80 | MP0001970_abnormal_pain_threshold | 1.24005165 |
| 81 | MP0005174_abnormal_tail_pigmentation | 1.22370425 |
| 82 | MP0002064_seizures | 1.21674680 |
| 83 | MP0003191_abnormal_cellular_cholesterol | 1.21346919 |
| 84 | MP0002138_abnormal_hepatobiliary_system | 1.18932236 |
| 85 | MP0000631_abnormal_neuroendocrine_gland | 1.18856982 |
| 86 | MP0002735_abnormal_chemical_nociception | 1.18618067 |
| 87 | MP0005386_behavior/neurological_phenoty | 1.17688875 |
| 88 | MP0004924_abnormal_behavior | 1.17688875 |
| 89 | MP0000230_abnormal_systemic_arterial | 1.17552597 |
| 90 | MP0001529_abnormal_vocalization | 1.16725891 |
| 91 | MP0005075_abnormal_melanosome_morpholog | 1.14995910 |
| 92 | MP0002938_white_spotting | 1.14737297 |
| 93 | MP0009379_abnormal_foot_pigmentation | 1.13376713 |
| 94 | MP0002557_abnormal_social/conspecific_i | 1.13050924 |
| 95 | MP0005085_abnormal_gallbladder_physiolo | 1.11672353 |
| 96 | MP0008775_abnormal_heart_ventricle | 1.10082747 |
| 97 | MP0005360_urolithiasis | 1.08736911 |
| 98 | MP0003121_genomic_imprinting | 1.08185031 |
| 99 | MP0004782_abnormal_surfactant_physiolog | 1.07902263 |
| 100 | MP0001485_abnormal_pinna_reflex | 1.07555988 |
| 101 | MP0003566_abnormal_cell_adhesion | 1.07278706 |
| 102 | MP0004185_abnormal_adipocyte_glucose | 1.07100262 |
| 103 | MP0009780_abnormal_chondrocyte_physiolo | 1.05904667 |
| 104 | MP0001905_abnormal_dopamine_level | 1.04457363 |
| 105 | MP0003635_abnormal_synaptic_transmissio | 1.04137464 |
| 106 | MP0002063_abnormal_learning/memory/cond | 1.03329029 |
| 107 | MP0002160_abnormal_reproductive_system | 1.03230898 |
| 108 | MP0003880_abnormal_central_pattern | 1.03175603 |
| 109 | MP0002653_abnormal_ependyma_morphology | 1.01567354 |
| 110 | MP0002148_abnormal_hypersensitivity_rea | 1.01016364 |
| 111 | MP0002734_abnormal_mechanical_nocicepti | 1.01014302 |
| 112 | MP0000372_irregular_coat_pigmentation | 1.00665666 |
| 113 | MP0004085_abnormal_heartbeat | 1.00136192 |
| 114 | MP0002139_abnormal_hepatobiliary_system | 1.00022705 |
| 115 | MP0003045_fibrosis | 0.97969128 |
| 116 | MP0001984_abnormal_olfaction | 0.97962336 |
| 117 | MP0010030_abnormal_orbit_morphology | 0.97836571 |
| 118 | MP0002067_abnormal_sensory_capabilities | 0.96021997 |
| 119 | MP0002095_abnormal_skin_pigmentation | 0.95419883 |
| 120 | MP0005379_endocrine/exocrine_gland_phen | 0.94686697 |
| 121 | MP0005195_abnormal_posterior_eye | 0.94586139 |
| 122 | MP0005167_abnormal_blood-brain_barrier | 0.94196510 |
| 123 | MP0001243_abnormal_dermal_layer | 0.92815150 |
| 124 | MP0005084_abnormal_gallbladder_morpholo | 0.92090793 |
| 125 | MP0001188_hyperpigmentation | 0.91931158 |
| 126 | MP0005389_reproductive_system_phenotype | 0.89632207 |
| 127 | MP0003755_abnormal_palate_morphology | 0.89385961 |
| 128 | MP0000538_abnormal_urinary_bladder | 0.89133777 |
| 129 | MP0005409_darkened_coat_color | 0.88380634 |
| 130 | MP0002132_abnormal_respiratory_system | 0.88122811 |
| 131 | MP0002822_catalepsy | 0.88027225 |
| 132 | MP0004084_abnormal_cardiac_muscle | 0.87733070 |
| 133 | MP0004130_abnormal_muscle_cell | 0.86980020 |
| 134 | MP0002928_abnormal_bile_duct | 0.81599379 |
| 135 | MP0001324_abnormal_eye_pigmentation | 0.80991427 |
| 136 | MP0010386_abnormal_urinary_bladder | 0.80924247 |
| 137 | MP0002693_abnormal_pancreas_physiology | 0.80806383 |
| 138 | MP0001340_abnormal_eyelid_morphology | 0.79101513 |
| 139 | MP0005448_abnormal_energy_balance | 0.78895723 |
| 140 | MP0005171_absent_coat_pigmentation | 0.76004823 |
| 141 | MP0002249_abnormal_larynx_morphology | 0.74525357 |
| 142 | MP0003705_abnormal_hypodermis_morpholog | 0.74279956 |
| 143 | MP0003436_decreased_susceptibility_to | 0.73649857 |
| 144 | MP0003950_abnormal_plasma_membrane | 0.73480136 |
| 145 | MP0008004_abnormal_stomach_pH | 0.71528429 |
| 146 | MP0009250_abnormal_appendicular_skeleto | 0.70485648 |
| 147 | MP0002177_abnormal_outer_ear | 0.63871670 |
| 148 | MP0002102_abnormal_ear_morphology | 0.62514633 |
| 149 | MP0010352_gastrointestinal_tract_polyps | 0.59765294 |
| 150 | MP0009697_abnormal_copulation | 0.57106270 |
| 151 | MP0001919_abnormal_reproductive_system | 0.55729343 |
| 152 | MP0003011_delayed_dark_adaptation | 0.55725919 |
| 153 | MP0002006_tumorigenesis | 0.55017828 |
| 154 | MP0000627_abnormal_mammary_gland | 0.54921443 |
| 155 | MP0002233_abnormal_nose_morphology | 0.53954599 |
| 156 | MP0003787_abnormal_imprinting | 0.53547764 |
| 157 | MP0000432_abnormal_head_morphology | 0.52959600 |
| 158 | MP0002109_abnormal_limb_morphology | 0.52627114 |
| 159 | MP0005508_abnormal_skeleton_morphology | 0.52389980 |
| 160 | MP0003315_abnormal_perineum_morphology | 0.50739732 |
| 161 | MP0002111_abnormal_tail_morphology | 0.49354696 |
| 162 | MP0005645_abnormal_hypothalamus_physiol | 0.49292136 |
| 163 | MP0009384_cardiac_valve_regurgitation | 0.48903380 |
| 164 | MP0006292_abnormal_olfactory_placode | 0.47726756 |
| 165 | MP0005197_abnormal_uvea_morphology | 0.46512899 |
| 166 | MP0003385_abnormal_body_wall | 0.45806022 |
| 167 | MP0003763_abnormal_thymus_physiology | 0.44760472 |
| 168 | MP0000470_abnormal_stomach_morphology | 0.44423970 |
| 169 | MP0005076_abnormal_cell_differentiation | 0.44419045 |
| 170 | MP0002998_abnormal_bone_remodeling | 0.44393665 |
| 171 | MP0006054_spinal_hemorrhage | 0.44209818 |
| 172 | MP0008789_abnormal_olfactory_epithelium | 0.44161666 |
| 173 | MP0003183_abnormal_peptide_metabolism | 0.44101070 |
| 174 | MP0005390_skeleton_phenotype | 0.43758127 |
| 175 | MP0005187_abnormal_penis_morphology | 0.43519677 |
| 176 | MP0009764_decreased_sensitivity_to | 0.42409893 |
| 177 | MP0008995_early_reproductive_senescence | 0.42073535 |
| 178 | MP0003828_pulmonary_edema | 0.41261218 |
| 179 | MP0005310_abnormal_salivary_gland | 0.40183486 |
| 180 | MP0002396_abnormal_hematopoietic_system | 0.40170957 |
| 181 | MP0001784_abnormal_fluid_regulation | 0.39754520 |
| 182 | MP0001286_abnormal_eye_development | 0.39595962 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Increased IgE level (HP:0003212) | 6.59488968 |
| 2 | Abnormality of nail color (HP:0100643) | 6.59004072 |
| 3 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 5.68026155 |
| 4 | Congenital ichthyosiform erythroderma (HP:0007431) | 5.61119580 |
| 5 | Hypotrichosis (HP:0001006) | 5.49903771 |
| 6 | Lip pit (HP:0100267) | 5.43296082 |
| 7 | Parakeratosis (HP:0001036) | 5.31869731 |
| 8 | Palmoplantar hyperkeratosis (HP:0000972) | 5.19460655 |
| 9 | Plantar hyperkeratosis (HP:0007556) | 5.17271169 |
| 10 | Palmar hyperkeratosis (HP:0010765) | 4.95337749 |
| 11 | Erythroderma (HP:0001019) | 4.62808317 |
| 12 | Woolly hair (HP:0002224) | 4.52871869 |
| 13 | Pancreatic cysts (HP:0001737) | 4.24392042 |
| 14 | Onycholysis (HP:0001806) | 4.22345298 |
| 15 | Erythema (HP:0010783) | 4.17122417 |
| 16 | Abnormality of midbrain morphology (HP:0002418) | 4.16916131 |
| 17 | Molar tooth sign on MRI (HP:0002419) | 4.16916131 |
| 18 | Sparse scalp hair (HP:0002209) | 4.05885112 |
| 19 | Right ventricular cardiomyopathy (HP:0011663) | 4.00439530 |
| 20 | Ectropion (HP:0000656) | 3.98315429 |
| 21 | Type II lissencephaly (HP:0007260) | 3.96840748 |
| 22 | Congenital stationary night blindness (HP:0007642) | 3.93468323 |
| 23 | Natal tooth (HP:0000695) | 3.92105463 |
| 24 | Pancreatic fibrosis (HP:0100732) | 3.76174809 |
| 25 | Abnormality of the renal cortex (HP:0011035) | 3.76016759 |
| 26 | Thick nail (HP:0001805) | 3.72215982 |
| 27 | Nephronophthisis (HP:0000090) | 3.68809594 |
| 28 | Gangrene (HP:0100758) | 3.48648650 |
| 29 | True hermaphroditism (HP:0010459) | 3.41209040 |
| 30 | Aplasia cutis congenita (HP:0001057) | 3.32411301 |
| 31 | Chronic hepatic failure (HP:0100626) | 3.31127956 |
| 32 | Medial flaring of the eyebrow (HP:0010747) | 3.30661296 |
| 33 | Attenuation of retinal blood vessels (HP:0007843) | 3.29532345 |
| 34 | Abnormality of the renal medulla (HP:0100957) | 3.28685938 |
| 35 | Corneal erosion (HP:0200020) | 3.25944050 |
| 36 | Fragile nails (HP:0001808) | 3.23785260 |
| 37 | Advanced eruption of teeth (HP:0006288) | 3.14712086 |
| 38 | Tubular atrophy (HP:0000092) | 3.13222191 |
| 39 | Hypohidrosis (HP:0000966) | 3.11924677 |
| 40 | Abnormal blistering of the skin (HP:0008066) | 3.09892853 |
| 41 | Polydipsia (HP:0001959) | 2.98147296 |
| 42 | Abnormal drinking behavior (HP:0030082) | 2.98147296 |
| 43 | Curly hair (HP:0002212) | 2.96517292 |
| 44 | Oligodontia (HP:0000677) | 2.85657643 |
| 45 | Renal cortical cysts (HP:0000803) | 2.82674468 |
| 46 | Hypothermia (HP:0002045) | 2.81258375 |
| 47 | Cystic liver disease (HP:0006706) | 2.77107767 |
| 48 | Distal lower limb muscle weakness (HP:0009053) | 2.75934517 |
| 49 | Hyperventilation (HP:0002883) | 2.74003611 |
| 50 | Decreased central vision (HP:0007663) | 2.72392804 |
| 51 | Keratoconus (HP:0000563) | 2.71825771 |
| 52 | Increased corneal curvature (HP:0100692) | 2.71825771 |
| 53 | Lissencephaly (HP:0001339) | 2.71243750 |
| 54 | Pruritus (HP:0000989) | 2.68923434 |
| 55 | Sparse eyelashes (HP:0000653) | 2.66909049 |
| 56 | Abnormality of secondary sexual hair (HP:0009888) | 2.63432752 |
| 57 | Abnormality of the axillary hair (HP:0100134) | 2.63432752 |
| 58 | Gait imbalance (HP:0002141) | 2.62711499 |
| 59 | Nail dystrophy (HP:0008404) | 2.62355354 |
| 60 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.61861694 |
| 61 | Alopecia of scalp (HP:0002293) | 2.59248466 |
| 62 | Cerebellar dysplasia (HP:0007033) | 2.57183230 |
| 63 | Corneal dystrophy (HP:0001131) | 2.53958821 |
| 64 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.51089106 |
| 65 | Abolished electroretinogram (ERG) (HP:0000550) | 2.49951450 |
| 66 | Conical tooth (HP:0000698) | 2.49363597 |
| 67 | Retinal dysplasia (HP:0007973) | 2.47138563 |
| 68 | Dry hair (HP:0011359) | 2.47052590 |
| 69 | Mesangial abnormality (HP:0001966) | 2.44629278 |
| 70 | Congenital primary aphakia (HP:0007707) | 2.43901707 |
| 71 | Milia (HP:0001056) | 2.43196653 |
| 72 | Popliteal pterygium (HP:0009756) | 2.40358971 |
| 73 | Palmoplantar keratoderma (HP:0000982) | 2.39038235 |
| 74 | Polyuria (HP:0000103) | 2.37061833 |
| 75 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.31298043 |
| 76 | Pachygyria (HP:0001302) | 2.30701047 |
| 77 | Acute necrotizing encephalopathy (HP:0006965) | 2.30046112 |
| 78 | Congenital hepatic fibrosis (HP:0002612) | 2.29974336 |
| 79 | Sclerocornea (HP:0000647) | 2.29845395 |
| 80 | Large for gestational age (HP:0001520) | 2.29479520 |
| 81 | Mitochondrial inheritance (HP:0001427) | 2.28709423 |
| 82 | Prostate neoplasm (HP:0100787) | 2.27828047 |
| 83 | Eczematoid dermatitis (HP:0000976) | 2.26848303 |
| 84 | Pendular nystagmus (HP:0012043) | 2.25709024 |
| 85 | Limb dystonia (HP:0002451) | 2.25570927 |
| 86 | Chorioretinal atrophy (HP:0000533) | 2.23758820 |
| 87 | Reticulocytopenia (HP:0001896) | 2.23067337 |
| 88 | Severe muscular hypotonia (HP:0006829) | 2.22810372 |
| 89 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.21845041 |
| 90 | Furrowed tongue (HP:0000221) | 2.20734253 |
| 91 | Pili torti (HP:0003777) | 2.20410042 |
| 92 | Hypergammaglobulinemia (HP:0010702) | 2.20226294 |
| 93 | Ketosis (HP:0001946) | 2.19080243 |
| 94 | Nephrogenic diabetes insipidus (HP:0009806) | 2.19009879 |
| 95 | Ventricular tachycardia (HP:0004756) | 2.18677734 |
| 96 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.17663119 |
| 97 | Delayed CNS myelination (HP:0002188) | 2.17168404 |
| 98 | Severe Myopia (HP:0011003) | 2.16857867 |
| 99 | Absent eyebrow (HP:0002223) | 2.16458978 |
| 100 | Inability to walk (HP:0002540) | 2.16456801 |
| 101 | Anhidrosis (HP:0000970) | 2.16337562 |
| 102 | Optic disc pallor (HP:0000543) | 2.15479881 |
| 103 | Gaze-evoked nystagmus (HP:0000640) | 2.15366338 |
| 104 | Increased CSF lactate (HP:0002490) | 2.15039091 |
| 105 | Abnormality of the preputium (HP:0100587) | 2.12774465 |
| 106 | Broad-based gait (HP:0002136) | 2.11792510 |
| 107 | White forelock (HP:0002211) | 2.10440054 |
| 108 | Abnormality of the nasal septum (HP:0000419) | 2.10207905 |
| 109 | Chromsome breakage (HP:0040012) | 2.10171042 |
| 110 | Duplicated collecting system (HP:0000081) | 2.09025905 |
| 111 | Progressive macrocephaly (HP:0004481) | 2.08366833 |
| 112 | Myelomeningocele (HP:0002475) | 2.03591391 |
| 113 | Decreased circulating renin level (HP:0003351) | 2.01394166 |
| 114 | Bile duct proliferation (HP:0001408) | 2.00736356 |
| 115 | Abnormal biliary tract physiology (HP:0012439) | 2.00736356 |
| 116 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.99184415 |
| 117 | Abnormality of alanine metabolism (HP:0010916) | 1.99184415 |
| 118 | Hyperalaninemia (HP:0003348) | 1.99184415 |
| 119 | Hypoplasia of the pons (HP:0012110) | 1.98848008 |
| 120 | Blepharitis (HP:0000498) | 1.98368457 |
| 121 | Abnormality of the pons (HP:0007361) | 1.98343149 |
| 122 | Abnormal urine output (HP:0012590) | 1.97076509 |
| 123 | Genital tract atresia (HP:0001827) | 1.96937827 |
| 124 | Abnormality of the renal collecting system (HP:0004742) | 1.96009090 |
| 125 | Hemiparesis (HP:0001269) | 1.95195298 |
| 126 | Patchy hypopigmentation of hair (HP:0011365) | 1.95154004 |
| 127 | Nasolacrimal duct obstruction (HP:0000579) | 1.94615558 |
| 128 | Progressive cerebellar ataxia (HP:0002073) | 1.93860379 |
| 129 | Concave nail (HP:0001598) | 1.93168472 |
| 130 | Congenital, generalized hypertrichosis (HP:0004540) | 1.92090594 |
| 131 | Ketoacidosis (HP:0001993) | 1.91583261 |
| 132 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.89550139 |
| 133 | Vaginal atresia (HP:0000148) | 1.88575928 |
| 134 | Hepatocellular necrosis (HP:0001404) | 1.88294945 |
| 135 | Congenital sensorineural hearing impairment (HP:0008527) | 1.88089202 |
| 136 | Dry skin (HP:0000958) | 1.87669875 |
| 137 | Acute encephalopathy (HP:0006846) | 1.86917554 |
| 138 | Fair hair (HP:0002286) | 1.85875873 |
| 139 | Hepatic necrosis (HP:0002605) | 1.85721030 |
| 140 | Genetic anticipation (HP:0003743) | 1.85393667 |
| 141 | Dehydration (HP:0001944) | 1.84010707 |
| 142 | Methylmalonic acidemia (HP:0002912) | 1.83362693 |
| 143 | Left ventricular hypertrophy (HP:0001712) | 1.83272732 |
| 144 | Prolonged QT interval (HP:0001657) | 1.82617785 |
| 145 | Male pseudohermaphroditism (HP:0000037) | 1.82232945 |
| 146 | 3-Methylglutaconic aciduria (HP:0003535) | 1.80716494 |
| 147 | Follicular hyperkeratosis (HP:0007502) | 1.80636485 |
| 148 | Anomalous pulmonary venous return (HP:0010772) | 1.80208943 |
| 149 | Hypoplastic labia majora (HP:0000059) | 1.80068449 |
| 150 | Volvulus (HP:0002580) | 1.79769380 |
| 151 | Tachypnea (HP:0002789) | 1.79451172 |
| 152 | Agitation (HP:0000713) | 1.79003046 |
| 153 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.78999157 |
| 154 | Upper limb muscle weakness (HP:0003484) | 1.78056269 |
| 155 | Focal seizures (HP:0007359) | 1.77202012 |
| 156 | Prominent supraorbital ridges (HP:0000336) | 1.76470485 |
| 157 | Abnormality of the right ventricle (HP:0001707) | 1.75572605 |
| 158 | Conjunctival hamartoma (HP:0100780) | 1.75467110 |
| 159 | Septo-optic dysplasia (HP:0100842) | 1.75038667 |
| 160 | Lipid accumulation in hepatocytes (HP:0006561) | 1.74248425 |
| 161 | Retinitis pigmentosa (HP:0000510) | 1.73909819 |
| 162 | Abnormality of the fetal cardiovascular system (HP:0010948) | 1.73836487 |
| 163 | Abnormal umbilical cord blood vessels (HP:0011403) | 1.73836487 |
| 164 | Single umbilical artery (HP:0001195) | 1.73836487 |
| 165 | Optic nerve hypoplasia (HP:0000609) | 1.73812680 |
| 166 | Anencephaly (HP:0002323) | 1.73595734 |
| 167 | Postaxial foot polydactyly (HP:0001830) | 1.73427259 |
| 168 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.72777764 |
| 169 | Abnormality of renal excretion (HP:0011036) | 1.72433460 |
| 170 | Bulbous nose (HP:0000414) | 1.71930237 |
| 171 | Postaxial hand polydactyly (HP:0001162) | 1.71796351 |
| 172 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.70458293 |
| 173 | Abnormality of the lacrimal duct (HP:0011481) | 1.70148398 |
| 174 | Poor coordination (HP:0002370) | 1.70123161 |
| 175 | Abnormality of urine glucose concentration (HP:0011016) | 1.69849356 |
| 176 | Glycosuria (HP:0003076) | 1.69849356 |
| 177 | Brittle hair (HP:0002299) | 1.69607365 |
| 178 | Abnormality of the middle phalanx of the 5th finger (HP:0004219) | 1.67503998 |
| 179 | Adrenal hypoplasia (HP:0000835) | 1.67079970 |
| 180 | Epidermoid cyst (HP:0200040) | 1.66425717 |
| 181 | Acanthosis nigricans (HP:0000956) | 1.66385813 |
| 182 | Recurrent abscess formation (HP:0002722) | 1.66365164 |
| 183 | Stomach cancer (HP:0012126) | 1.64859963 |
| 184 | Abnormality of incisor morphology (HP:0011063) | 1.64212792 |
| 185 | Laryngomalacia (HP:0001601) | 1.62453142 |
| 186 | Premature loss of primary teeth (HP:0006323) | 1.61365854 |
| 187 | Abnormality of the phalanges of the 5th finger (HP:0004213) | 1.60785868 |
| 188 | Malignant hyperthermia (HP:0002047) | 1.59970599 |
| 189 | Abnormal sex determination (HP:0012244) | 1.59560706 |
| 190 | Sex reversal (HP:0012245) | 1.59560706 |
| 191 | Sepsis (HP:0100806) | 1.59296649 |
| 192 | Abnormality of the labia majora (HP:0012881) | 1.57619298 |
| 193 | Abnormality of the pulmonary veins (HP:0011718) | 1.53794809 |
| 194 | Alveolar cell carcinoma (HP:0006519) | 1.52957341 |
| 195 | Ulnar claw (HP:0001178) | 1.50220991 |
| 196 | Skin pits (HP:0100276) | 1.48765090 |
| 197 | Abnormality of the gastric mucosa (HP:0004295) | 1.46889804 |
| 198 | Hypoplasia of dental enamel (HP:0006297) | 1.46439163 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 5.98524604 |
| 2 | WNK4 | 3.14602299 |
| 3 | MAP3K3 | 2.90227418 |
| 4 | ACVR1B | 2.64768636 |
| 5 | LATS1 | 2.63255823 |
| 6 | EPHA3 | 2.57123335 |
| 7 | MAP4K2 | 2.47639768 |
| 8 | WNK3 | 2.46214337 |
| 9 | CASK | 2.44946930 |
| 10 | TLK1 | 2.35812090 |
| 11 | GRK7 | 2.35507864 |
| 12 | MAP3K14 | 2.33125522 |
| 13 | MUSK | 2.30069111 |
| 14 | TGFBR2 | 2.23193726 |
| 15 | ZAK | 2.22266337 |
| 16 | STK24 | 2.21840114 |
| 17 | FER | 2.15652530 |
| 18 | MST1R | 2.14855060 |
| 19 | EIF2AK2 | 2.12528726 |
| 20 | EPHB2 | 2.10551030 |
| 21 | MAPKAPK3 | 2.06784741 |
| 22 | DAPK2 | 2.00837619 |
| 23 | SRPK1 | 1.99590510 |
| 24 | MST4 | 1.97430456 |
| 25 | STK38L | 1.97298106 |
| 26 | CDK3 | 1.92730367 |
| 27 | PHKG2 | 1.90177254 |
| 28 | PHKG1 | 1.90177254 |
| 29 | GRK1 | 1.88746729 |
| 30 | MAPK13 | 1.84345024 |
| 31 | IRAK3 | 1.82242910 |
| 32 | INSRR | 1.81794719 |
| 33 | SIK3 | 1.78175902 |
| 34 | PAK3 | 1.77497088 |
| 35 | BLK | 1.66331378 |
| 36 | PINK1 | 1.63855893 |
| 37 | CDK8 | 1.62151174 |
| 38 | BMPR1B | 1.60102842 |
| 39 | MARK1 | 1.58234471 |
| 40 | MAP3K6 | 1.57613946 |
| 41 | PIM2 | 1.57459736 |
| 42 | MAP3K4 | 1.49800419 |
| 43 | CAMKK2 | 1.41935686 |
| 44 | CDK12 | 1.38783887 |
| 45 | NTRK3 | 1.33320057 |
| 46 | TAOK3 | 1.32947089 |
| 47 | ERBB3 | 1.31981733 |
| 48 | OXSR1 | 1.31902634 |
| 49 | NUAK1 | 1.31447764 |
| 50 | STK3 | 1.17674054 |
| 51 | TXK | 1.16755643 |
| 52 | STK10 | 1.12486144 |
| 53 | NTRK2 | 1.08247913 |
| 54 | TIE1 | 1.08031233 |
| 55 | YES1 | 1.05682748 |
| 56 | TAOK2 | 1.03440979 |
| 57 | IRAK4 | 1.01933378 |
| 58 | MAPK15 | 1.00738879 |
| 59 | PBK | 1.00658749 |
| 60 | TGFBR1 | 1.00527228 |
| 61 | STK39 | 0.99588987 |
| 62 | NME1 | 0.99375335 |
| 63 | BCKDK | 0.95859535 |
| 64 | ICK | 0.95449554 |
| 65 | PKN1 | 0.93188891 |
| 66 | DYRK2 | 0.93046097 |
| 67 | PRKCG | 0.93012608 |
| 68 | NLK | 0.91683725 |
| 69 | MAPKAPK2 | 0.90259015 |
| 70 | BRD4 | 0.90088860 |
| 71 | SIK2 | 0.89278649 |
| 72 | FGFR2 | 0.86654310 |
| 73 | TRPM7 | 0.86352077 |
| 74 | PIK3CA | 0.86192974 |
| 75 | PTK2B | 0.84582881 |
| 76 | TEC | 0.83836317 |
| 77 | BMPR2 | 0.81908547 |
| 78 | MAP3K5 | 0.81516181 |
| 79 | IKBKB | 0.81283743 |
| 80 | MAP2K7 | 0.80416872 |
| 81 | CSNK1G1 | 0.80211033 |
| 82 | TYK2 | 0.79501735 |
| 83 | CDK7 | 0.78592812 |
| 84 | CSNK1G3 | 0.78578720 |
| 85 | IRAK1 | 0.76873378 |
| 86 | ADRBK2 | 0.74784093 |
| 87 | CSNK1G2 | 0.74697520 |
| 88 | BCR | 0.74319356 |
| 89 | PRKAA2 | 0.73854030 |
| 90 | PIK3CG | 0.73053012 |
| 91 | CDK6 | 0.72205007 |
| 92 | MYLK | 0.72075609 |
| 93 | ITK | 0.71781480 |
| 94 | CAMK1 | 0.71717818 |
| 95 | RPS6KB2 | 0.69442594 |
| 96 | CHUK | 0.67929814 |
| 97 | JAK1 | 0.66195338 |
| 98 | MAP2K2 | 0.65819329 |
| 99 | STK11 | 0.64852377 |
| 100 | CAMK2A | 0.64571288 |
| 101 | RPS6KA4 | 0.64198364 |
| 102 | EPHA4 | 0.64049367 |
| 103 | IKBKE | 0.62478296 |
| 104 | MARK3 | 0.60910697 |
| 105 | ERBB2 | 0.60771835 |
| 106 | LIMK1 | 0.59718314 |
| 107 | CAMK4 | 0.59359381 |
| 108 | GRK5 | 0.59147232 |
| 109 | RPS6KC1 | 0.58324938 |
| 110 | RPS6KL1 | 0.58324938 |
| 111 | PRKAA1 | 0.56888602 |
| 112 | IRAK2 | 0.56306762 |
| 113 | PRKACA | 0.55851049 |
| 114 | MAPKAPK5 | 0.55566418 |
| 115 | SGK2 | 0.54507881 |
| 116 | TNIK | 0.52967527 |
| 117 | ERBB4 | 0.52537598 |
| 118 | RIPK4 | 0.49960649 |
| 119 | MAP3K2 | 0.49685907 |
| 120 | MAP2K4 | 0.49107439 |
| 121 | CSNK1A1L | 0.48567416 |
| 122 | MAPK7 | 0.47761009 |
| 123 | PLK2 | 0.47463697 |
| 124 | PRKCE | 0.47133774 |
| 125 | CAMKK1 | 0.46693411 |
| 126 | OBSCN | 0.46269144 |
| 127 | PRKCI | 0.46120846 |
| 128 | KIT | 0.46042755 |
| 129 | MKNK2 | 0.45857067 |
| 130 | MAP2K6 | 0.44745675 |
| 131 | MAP2K1 | 0.44047112 |
| 132 | PRKCZ | 0.43438768 |
| 133 | MARK2 | 0.43043436 |
| 134 | TNK2 | 0.41779489 |
| 135 | AKT2 | 0.41436578 |
| 136 | RPS6KA6 | 0.41132511 |
| 137 | EPHA2 | 0.40487787 |
| 138 | ADRBK1 | 0.40397967 |
| 139 | TBK1 | 0.39800247 |
| 140 | RPS6KA2 | 0.38138355 |
| 141 | CAMK2D | 0.37455736 |
| 142 | PRKCA | 0.37219075 |
| 143 | STK38 | 0.37048520 |
| 144 | PTK6 | 0.36360794 |
| 145 | CSNK1A1 | 0.35792342 |
| 146 | TTK | 0.35721184 |
| 147 | MAP2K3 | 0.34761710 |
| 148 | MAP3K12 | 0.34713431 |
| 149 | FGFR3 | 0.34371436 |
| 150 | BTK | 0.33415957 |
| 151 | RPS6KA1 | 0.33272391 |
| 152 | PRKD2 | 0.33268900 |
| 153 | PRKCQ | 0.32410837 |
| 154 | PIM1 | 0.32384855 |
| 155 | MET | 0.31426925 |
| 156 | AURKB | 0.31231525 |
| 157 | CSNK1D | 0.30933494 |
| 158 | MAP3K7 | 0.30929995 |
| 159 | ROCK1 | 0.29831291 |
| 160 | PRKG1 | 0.29716034 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 3.18401961 |
| 2 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.46897829 |
| 3 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.44283169 |
| 4 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.40758842 |
| 5 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.19801816 |
| 6 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 2.18138677 |
| 7 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.16184056 |
| 8 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.04646620 |
| 9 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.86643457 |
| 10 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.86346975 |
| 11 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.85257517 |
| 12 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.82772026 |
| 13 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.73651700 |
| 14 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.71987434 |
| 15 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.68666991 |
| 16 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.64964298 |
| 17 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.62723210 |
| 18 | Axon guidance_Homo sapiens_hsa04360 | 1.59323498 |
| 19 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.54343218 |
| 20 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.52087677 |
| 21 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.51661979 |
| 22 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.51643668 |
| 23 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.49581638 |
| 24 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.49012669 |
| 25 | Peroxisome_Homo sapiens_hsa04146 | 1.46287533 |
| 26 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.45516273 |
| 27 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.44395669 |
| 28 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.42064103 |
| 29 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.41769634 |
| 30 | Phototransduction_Homo sapiens_hsa04744 | 1.39275149 |
| 31 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.38982925 |
| 32 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.37686984 |
| 33 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.37423241 |
| 34 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.35037439 |
| 35 | RNA polymerase_Homo sapiens_hsa03020 | 1.34603928 |
| 36 | Protein export_Homo sapiens_hsa03060 | 1.34573648 |
| 37 | Ribosome_Homo sapiens_hsa03010 | 1.32294034 |
| 38 | Parkinsons disease_Homo sapiens_hsa05012 | 1.26676132 |
| 39 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.26655604 |
| 40 | Renin secretion_Homo sapiens_hsa04924 | 1.23737652 |
| 41 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.23641190 |
| 42 | Retinol metabolism_Homo sapiens_hsa00830 | 1.20996937 |
| 43 | Adherens junction_Homo sapiens_hsa04520 | 1.20421933 |
| 44 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.20021619 |
| 45 | Insulin secretion_Homo sapiens_hsa04911 | 1.19816416 |
| 46 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.15098873 |
| 47 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.14769472 |
| 48 | Pertussis_Homo sapiens_hsa05133 | 1.12910765 |
| 49 | Melanoma_Homo sapiens_hsa05218 | 1.12888733 |
| 50 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 1.07776261 |
| 51 | GABAergic synapse_Homo sapiens_hsa04727 | 1.07592508 |
| 52 | Circadian rhythm_Homo sapiens_hsa04710 | 1.07327538 |
| 53 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.07277247 |
| 54 | Morphine addiction_Homo sapiens_hsa05032 | 1.07264988 |
| 55 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.07019691 |
| 56 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.06905207 |
| 57 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.06821030 |
| 58 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.06716273 |
| 59 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.05912911 |
| 60 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.03966190 |
| 61 | Tuberculosis_Homo sapiens_hsa05152 | 1.03687663 |
| 62 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.02971454 |
| 63 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.01595241 |
| 64 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.98798902 |
| 65 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.98500829 |
| 66 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.98332733 |
| 67 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.97849916 |
| 68 | Basal transcription factors_Homo sapiens_hsa03022 | 0.97317930 |
| 69 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.97141356 |
| 70 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.96579486 |
| 71 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.96401592 |
| 72 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.95740526 |
| 73 | Malaria_Homo sapiens_hsa05144 | 0.94731661 |
| 74 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.94503326 |
| 75 | Mineral absorption_Homo sapiens_hsa04978 | 0.93159366 |
| 76 | Circadian entrainment_Homo sapiens_hsa04713 | 0.91601298 |
| 77 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.91392217 |
| 78 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.90658011 |
| 79 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.88297659 |
| 80 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.88204701 |
| 81 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.88018791 |
| 82 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.88010098 |
| 83 | Alzheimers disease_Homo sapiens_hsa05010 | 0.87737463 |
| 84 | Huntingtons disease_Homo sapiens_hsa05016 | 0.87600736 |
| 85 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.86921954 |
| 86 | Nicotine addiction_Homo sapiens_hsa05033 | 0.86678462 |
| 87 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.86475290 |
| 88 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.85512923 |
| 89 | Olfactory transduction_Homo sapiens_hsa04740 | 0.83562138 |
| 90 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.82882509 |
| 91 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.82478385 |
| 92 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.82132387 |
| 93 | Phagosome_Homo sapiens_hsa04145 | 0.81831234 |
| 94 | Histidine metabolism_Homo sapiens_hsa00340 | 0.81101635 |
| 95 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.80852571 |
| 96 | Hepatitis C_Homo sapiens_hsa05160 | 0.80660550 |
| 97 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.80617199 |
| 98 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.80436665 |
| 99 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.79291169 |
| 100 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.79234785 |
| 101 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.79125438 |
| 102 | Leishmaniasis_Homo sapiens_hsa05140 | 0.78459668 |
| 103 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.78418082 |
| 104 | Influenza A_Homo sapiens_hsa05164 | 0.78246165 |
| 105 | Sulfur relay system_Homo sapiens_hsa04122 | 0.77763022 |
| 106 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.77056589 |
| 107 | Cocaine addiction_Homo sapiens_hsa05030 | 0.76085745 |
| 108 | ABC transporters_Homo sapiens_hsa02010 | 0.75808729 |
| 109 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.75038871 |
| 110 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.74549228 |
| 111 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.74469611 |
| 112 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.73035399 |
| 113 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.72090424 |
| 114 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.69553543 |
| 115 | Homologous recombination_Homo sapiens_hsa03440 | 0.69388796 |
| 116 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.69358999 |
| 117 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.69310303 |
| 118 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.68675029 |
| 119 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.68446538 |
| 120 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.68376465 |
| 121 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.68274994 |
| 122 | Taste transduction_Homo sapiens_hsa04742 | 0.67576278 |
| 123 | Metabolic pathways_Homo sapiens_hsa01100 | 0.67199171 |
| 124 | Endometrial cancer_Homo sapiens_hsa05213 | 0.66839501 |
| 125 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.66533605 |
| 126 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.66431912 |
| 127 | RNA degradation_Homo sapiens_hsa03018 | 0.65709722 |
| 128 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.65704700 |
| 129 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.65275447 |
| 130 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.65097198 |
| 131 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.63623236 |
| 132 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.61401399 |
| 133 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.61131468 |
| 134 | Salivary secretion_Homo sapiens_hsa04970 | 0.60788533 |
| 135 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.59754500 |
| 136 | Apoptosis_Homo sapiens_hsa04210 | 0.59642300 |
| 137 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.59219210 |
| 138 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.58039574 |
| 139 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.58005804 |
| 140 | Measles_Homo sapiens_hsa05162 | 0.57922397 |
| 141 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.57793525 |
| 142 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.57364506 |
| 143 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.57088972 |
| 144 | Long-term depression_Homo sapiens_hsa04730 | 0.56001455 |
| 145 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.55320936 |
| 146 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.55085158 |
| 147 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.54378167 |
| 148 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.54367691 |
| 149 | Allograft rejection_Homo sapiens_hsa05330 | 0.54356779 |
| 150 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.53900342 |
| 151 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.53751405 |
| 152 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.53162607 |
| 153 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.52510602 |
| 154 | Prostate cancer_Homo sapiens_hsa05215 | 0.50482654 |
| 155 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.50341077 |
| 156 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.49812283 |
| 157 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.49205666 |
| 158 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.48880898 |
| 159 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.47494179 |
| 160 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.47373865 |
| 161 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.47321726 |
| 162 | Lysine degradation_Homo sapiens_hsa00310 | 0.47010123 |
| 163 | Pathways in cancer_Homo sapiens_hsa05200 | 0.46699333 |
| 164 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.46272345 |
| 165 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.45405853 |
| 166 | Other glycan degradation_Homo sapiens_hsa00511 | 0.45053199 |
| 167 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.44453066 |
| 168 | Bile secretion_Homo sapiens_hsa04976 | 0.41464518 |
| 169 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.38843380 |
| 170 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.38651662 |

